1351890267-1144543684.jpg

FDA New Drug and Biologic Approvals, 2018 Midyear Review

In This Issue 

The FDA New Drug and Biologic Approvals, 2018 Midyear Review describes new molecular entities, new biologics, and select new indications by condition for those drugs and biologics approved during the first half of this year. Each summary contains information on the indication, mechanism, dosage, and clinical trials that served as the basis for the FDA approval. For more information, each drug or biologic is linked to its corresponding Medscape drug monograph.

Primary Care

Hematology/Oncology

Infectious Disease

Neurology

Pediatrics

 

 

 

文章標籤
創作者介紹
創作者 快樂小藥師 的頭像
快樂小藥師

快樂小藥師 Im pharmacist nichts glücklich

快樂小藥師 發表在 痞客邦 留言(0) 人氣()